Delirium
Drug research and approvals for delirium: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 209 studies of delirium are recruiting on ClinicalTrials.gov, and Health Canada has authorized 5 drug trials for it since 2013.
- Recruiting worldwide: 209
- Trials authorized in Canada: 5
- FDA orphan approvals: 0
- EU medicines: 0
- The Impact of Fast-Track Anesthesia on Postoperative Neurocognitive Function in Patients Undergoing Cardiac SurgeryNCT07923344 · Not reported · Second Affiliated Hospital of Nanchang University · starts Jan 1, 2026
- The Effect of Remimazolam Tosylate on the Incidence of Postoperative Delirium in Older Patients Undergoing Cardiac…NCT07908121 · Not applicable · Nanjing First Hospital, Nanjing Medical University · starts Sep 5, 2026
- Low Pneumoperitoneum Pressure for Delirium Prevention in Elderly LaparoscopyNCT07906444 · Not applicable · Benha University · starts Oct 26, 2026
- Lactium Premedication to Prevent Emergence AgitationNCT07894484 · Phase 3 · Tanta University · starts Nov 4, 2026
- Mechanisms and Intervention Strategies of Perioperative Glycemic Variability on Postoperative DeliriumNCT07893353 · Not applicable · Fujian Medical University Union Hospital · starts Mar 1, 2026
- Immunonutrition and Neuromonitoring for Postoperative Delirium in Gynecologic OncologyNCT07877285 · Not reported · Elazıg Fethi Sekin Sehir Hastanesi · starts Oct 1, 2026
- Dexmedetomidine for Prevention of Delirium After Hip Fracture SurgeryNCT07867899 · Not reported · Peter Gaarsdal Uhrbrand · starts Oct 1, 2026
- Mobilisation After Endovascular Stroke TreatmentNCT07860333 · Not reported · Karolinska Institutet · starts May 7, 2026
- Total Intravenous Versus Inhalational Anesthesia in Patients Undergoing Hip Fracture SurgeryNCT07860996 · Not reported · Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital · starts Sep 30, 2026
Phase 3 12 of 21
- DexmedetomidineAdrenergic receptor alpha-2 agonist
- HaloperidolSerotonin 2a (5-HT2a) receptor antagonist
- MelatoninMelatonin receptor agonist
- QuetiapineSerotonin 2a (5-HT2a) receptor antagonist
- RivastigmineCholinesterases; ACHE & BCHE inhibitor
- ClonidineAdrenergic receptor alpha-2 agonist
- MidazolamGABA-A receptor; anion channel positive allosteric modulator
- AcetaminophenCyclooxygenase inhibitor
- NalbuphineOpioid receptors; mu/kappa/delta agonist
- KetamineGlutamate [NMDA] receptor negative allosteric modulator
- SuvorexantOrexin receptor antagonist
- LiraglutideGlucagon-like peptide 1 receptor agonist
Phase 2 7
- LorazepamGABA-A receptor; anion channel positive allosteric modulator
- FentanylMu opioid receptor agonist
- Haloperidol decanoateSerotonin 2a (5-HT2a) receptor antagonist
- OlanzapineSerotonin 2a (5-HT2a) receptor antagonist
- ChlorpromazineSerotonin 2a (5-HT2a) receptor antagonist
- SevofluraneGlycine receptor (alpha-1/beta) positive modulator
- XenonDiagnostic agent
Phase 1 or earlier 4
- Insulin humanInsulin receptor agonist
- Insulin porkInsulin receptor agonist
- SufentanilMu opioid receptor agonist
- EsketamineGlutamate [NMDA] receptor negative allosteric modulator
How its trials ended
995 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 155 whose ending is known, 23% met their primary endpoint, 17% missed it and 60% stopped early.
- Completed, result not reported38839%
- Ongoing25926%
- Status unknown19319%
- Stopped: other or unclear586%
- Met its primary endpoint354%
- Missed its primary endpoint273%
- Stopped: enrollment or feasibility253%
- Stopped: lack of efficacy4<1%
- Stopped: funding3<1%
- Stopped: sponsor or business decision2<1%
- Stopped: safety1<1%
| Mar 31, 2025 | Deldex: reducing days delirious with dexmedetomidine as part of an intensive care unit sleep promotion bundle - a pilot trial.Dexmedetomidine | The Governors of The University of Alberta | Pending |
| Oct 7, 2024 | A randomized trial of lemborexant for the prevention of delirium after cardiac surgery (protex trial)Lemborexant | Providence Health Care-Saint Paul's Hospital | Ongoing |
| May 7, 2021 | Effects of dexmedetomidine in adult patients with agitated delirium in palliative care: an open-label phase I/II proof-of-concept, dose-finding, and…Dexmedetomidine | Bruyère Health Research Institute | Ongoing |
| Aug 9, 2018 | Does intranasal insulin administration reduce the incidence of delirium after cardiac surgery?Humulin r | McGill University Health Centre | Pending |
| Jun 24, 2013 | Haloperidol prophylaxis in cardiac surgery for patients at risk for delirium: a randomized placebo-controlled pilot studyHaloperidol | Hamilton Health Sciences Corporation | Ongoing |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA